Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of 112.88 billion as of December 5, 2025. Its market cap has increased by 30.82% in one year.

Market Cap

112.88B

Enterprise Value

123.66B

Revenue

21.64B

Ranking

n/a

PE Ratio

18.71

Stock Price

123.41

Market Cap Chart

Since January 22, 1992, Gilead Sciences's market cap has increased from 138.73M to 112.88B, an increase of 81,267.75%. That is a compound annual growth rate of 21.86%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	112.88B	22.76%
Dec 31, 2024	91.95B	16.03%
Dec 29, 2023	79.25B	-11.32%
Dec 30, 2022	89.37B	32.86%
Dec 31, 2021	67.26B	25.75%
Dec 31, 2020	53.49B	-13.83%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	214.00B
HSBC Holdings	186.52B
Shell	160.35B
Unilever	111.61B
British American Tobacco p.l.c.	95.57B
Rio Tinto Group	92.82B
Rolls-Royce Holdings	87.56B
GSK plc	73.02B

Market Cap Rankings